Blueweave
United States Hospital And Nursing Home Probiotics Market

United States Hospital And Nursing Home Probiotics Market

United States Hospital and Nursing Home Probiotics Market, By Product Type (Dietary Supplements, Functional Foods & Beverages, Medical Foods, Probiotic-based Pharmaceuticals); By Formulation (Powder, Liquid, Capsules/Tablets, Others (Gels, Chewable Forms); By Application (Digestive Health, Immune System Support, Antibiotic-associated Diarrhea (AAD), Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores, Direct Sales), Trend Analysis, Competitive Landscape & Forecast, 2019–2030

  • Published Date: October 2024
  • Report ID: BWC24747
  • Available Format: PDF
  • Page: 128

Report Overview

A rising demand for preventive healthcare, growing awareness about the benefits of probiotics, adoption of technological advancements, and a shift toward healthier lifestyles are expected to drive United States Hospital and Nursing Home Probiotics Market during the forecast period between 2024 and 2030.

United States Hospital and Nursing Home Probiotics Market – Industry Trends & Forecast Report, 2030

United States Hospital and Nursing Home Probiotics Market size by value was estimated at USD 110.20 million in 2023. During the forecast period between 2024 and 2030, United States Hospital and Nursing Home Probiotics Market size is expected to expand at a CAGR of 9.10% reaching a value of USD 197.76 million by 2030. United States Hospital and Nursing Home Probiotics Market is driven by several factors, including increased demand for preventative healthcare and natural products, and increased awareness of the health benefits of probiotics. Additionally, the shift towards healthier lifestyles, the growing geriatric population, and the need to reduce healthcare costs through improved patient outcomes are significant contributors. The market is also bolstered by collaborative efforts between manufacturers and healthcare institutions to promote probiotic use.

United States Hospital and Nursing Home Probiotics Market

Hospital and Nursing Home Probiotics – Overview

Hospital and nursing home probiotics are live microorganisms that, when administered in adequate amounts, confer health benefits to the host. These probiotics are used to improve digestive health, boost immunity, and reduce the risk of infections among patients. They are available in various forms, including dietary supplements and fermented foods like yogurt, sauerkraut, and kimchi. Probiotics are particularly beneficial in healthcare settings for enhancing patient outcomes and reducing healthcare costs through preventive care.

United States Hospital and Nursing Home Probiotics Market      

Growth Drivers

Rising Awareness about Gut Health

Increasing awareness about gut health is a significant growth driver for United States Hospital And Nursing Home Probiotics Market. As more people understand the crucial role of gut microbiota in overall health, there is a growing demand for probiotics to enhance digestive health and immunity. This awareness is particularly important in healthcare settings, where probiotics are used to improve patient outcomes, reduce infection rates, and promote faster recovery.

Challenges

Limited Reimbursement

A significant restraint in United States Hospital and Nursing Home Probiotics Market is the limited reimbursement policies. Probiotics are often not covered under standard health insurance plans, making them an out-of-pocket expense for many patients. This financial burden can deter healthcare facilities from recommending probiotics, despite their potential benefits. The lack of reimbursement options limits the accessibility and adoption of probiotics in clinical settings, thereby hindering market growth.

Impact of Escalating Geopolitical Tensions on United States Hospital and Nursing Home Probiotics Market    

Intensifying and further spreading of geopolitical tensions could adversely affect United States Hospital And Nursing Home Probiotics Market. Disruptions in global supply chains, particularly for raw materials and finished products, can lead to shortages and increased costs. Heightened geopolitical risks may also result in stricter trade regulations and tariffs, further complicating the import of probiotics. Additionally, economic instability caused by geopolitical conflicts can reduce healthcare budgets, limiting the adoption of non-essential health products like probiotics. These factors collectively hinder market growth and accessibility, making it challenging for healthcare facilities to maintain a steady supply of probiotics for patient care.

United States Hospital and Nursing Home Probiotics Market

Segmental Information

United States Hospital and Nursing Home Probiotics Market – By Product Type

By product type, United States Hospital and Nursing Home Probiotics Market is divided into Dietary Supplements, Functional Foods & Beverages, Medical Foods, and Probiotic-based Pharmaceuticals segments. The dietary supplement segment is the largest product type in United States Hospital and Nursing Home Probiotics Market. Probiotics in dietary supplements have gained widespread acceptance due to their convenience, health benefits, and increasing use among hospital and nursing home patients to support digestive health, immune function, and overall well-being. These supplements are easy to administer and often recommended by healthcare professionals to improve gut health, particularly for elderly patients. The growing preference for natural health products in clinical settings further drives the demand for probiotic-based dietary supplements in hospitals and nursing homes.

United States Hospital and Nursing Home Probiotics Market Size

United States Hospital and Nursing Home Probiotics Market – By Application

Based on application, United States Hospital and Nursing Home Probiotics Market is divided into Digestive Health, Immune System Support, Antibiotic-associated Diarrhea (AAD), and other segments. The digestive health segment holds the largest share of United States Hospital and Nursing Home Probiotics Market by application. The segment’s dominance is driven by the increasing use of probiotics to promote gut health, manage conditions like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), and enhance overall digestive function. Probiotics' role in improving nutrient absorption, reducing gastrointestinal infections, and supporting bowel regularity is highly valued in hospital and nursing home settings. Additionally, awareness about the benefits of probiotics in preventing and managing various digestive disorders has fueled the demand for probiotics in this segment.

United States Hospital and Nursing Home Probiotics Market Share

United States Hospital and Nursing Home Probiotics Market – By Distribution Channel

On the basis of distribution channel, United States Hospital and Nursing Home Probiotics Market is divided into Hospital Pharmacies, Retail Pharmacies, Online Stores, and Direct Sales segments. The hospital pharmacies segment is the largest distribution channel of United States Hospital and Nursing Home Probiotics Market. The dominance is driven by the trust healthcare providers place in probiotics for managing various gastrointestinal and immune health conditions in both hospitals and nursing homes. Probiotics are often prescribed or recommended by physicians and dispensed directly through hospital pharmacies to ensure immediate access and high-quality control. Additionally, healthcare settings prioritize medical-grade probiotics for patients undergoing treatments that may affect their gut health, further contributing to the prominence of hospital pharmacies in this market segment.

Competitive Landscape

Key players in the highly competitive United States Hospital and Nursing Home Probiotics Market include Danone, Nestlé, Yakult Honsha, Probi AB, Chr. Hansen Holding A/S, DuPont de Nemours Inc., BioGaia AB, Lallemand Inc., Sabinsa Corporation, and Nebraska Cultures Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2023

Base Year – 2023

Estimated Year – 2024

Forecast Period – 2024–2030

Facts Covered

Revenue in USD Million 

Market Coverage

United States

Product/Service Segmentation

Product Type, Formulation, Application, Distribution Channel

Key Players

Danone, Nestlé, Yakult Honsha, Probi AB, Chr. Hansen Holding A/S, DuPont de Nemours Inc., BioGaia AB, Lallemand Inc., Sabinsa Corporation, Nebraska Cultures Inc.

 

By Product Type

  • Dietary Supplements

  • Functional Foods & Beverages

  • Medical Foods

  • Probiotic-based Pharmaceuticals

By Formulation

  • Powder

  • Liquid

  • Capsules/Tablets

  • Others (Gels, Chewable Forms)

By Application

  • Digestive Health

  • Immune System Support

  • Antibiotic-associated diarrhea (AAD)

  • Others

By Distribution Channel

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Stores

  • Direct Sales

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. United States Hospital and Nursing Home Probiotics Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Rising Awareness of Gut Health
        2. Antibiotic-Associated Diarrhea (AAD)
        3. Infectious Disease Prevention
      2. Restraints
        1. High Costs
        2. Limited Reimbursement
      3. Opportunities
        1. Aging Population
        2. Improved Patient Outcomes
      4. Challenges
        1. Variable Efficacy
        2. Potential Side Effects
    3. Technological Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. United States Hospital and Nursing Home Probiotics Market: Marketing Strategies
  5. United States Hospital and Nursing Home Probiotics Market: Pricing Analysis
  6. United States Hospital and Nursing Home Probiotics Market Overview
    1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product Type
        1. Dietary Supplements
        2. Functional Foods & Beverages
        3. Medical Foods
        4. Probiotic-based Pharmaceuticals
      2. By Formulation
        1. Powder
        2. Liquid
        3. Capsules/Tablets
        4. Others (Gels, Chewable Forms)
      3. By Application
        1. Digestive Health
        2. Immune System Support
        3. Antibiotic-associated Diarrhea (AAD)
        4. Others
      4. By Distribution Channel
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Stores
        4. Direct Sales
  7. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. United States Hospital and Nursing Home Probiotics Company Market Share Analysis, 2023
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  8. Impact of Escalating Geopolitical Tensions on United States Hospital and Nursing Home Probiotics Market
  9. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1. Danone
    2. Nestlé
    3. Yakult Honsha
    4. Probi AB
    5. Chr. Hansen Holding A/S
    6. DuPont de Nemours Inc.
    7. BioGaia AB
    8. Lallemand Inc.
    9. Sabinsa Corporation
    10. Nebraska Cultures Inc
    11. Other Prominent Players
  10. Key Strategic Recommendations
  11. Research Methodology
    1. Qualitative Research
      1.   Primary & Secondary Research
    2.    Quantitative Research
    3.    Market Breakdown & Data Triangulation
      1.   Secondary Research
      2.   Primary Research
    4. Breakdown of Primary Research Respondents, By Region
    5.    Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.

 

List of Figures

 

Figure 1       United States Hospital and Nursing Home Probiotics  Segmentation

Figure 2       United States Hospital and Nursing Home Probiotics  Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2023

Figure 4       United States Hospital and Nursing Home Probiotics  Market Size, By Value (USD Million), 2019–2030

Figure 5       United States Hospital and Nursing Home Probiotics  Market Share, By Product Type,  By Value, 2019–2030

Figure 6       United States Hospital and Nursing Home Probiotics  Market Share, By Formulations, By Value, 2019–2030

Figure 7       United States Hospital and Nursing Home Probiotics  Market Share, By Application,  By Value, 2019–2030

Figure 8       United States Hospital and Nursing Home Probiotics  Market Share, By Distribution Channel, By Value, 2019–2030

 

List of Tables

 

Table 1        United States Hospital and Nursing Home Probiotics  Market Size, By Value (USD Million), 2019–2030

Table 2        United States Hospital and Nursing Home Probiotics  Market Size, By Product Type,  By Value, 2019–2030

Table 3        United States Hospital and Nursing Home Probiotics  Market Size, By Formulations, By Value, 2019–2030

Table 4        United States Hospital and Nursing Home Probiotics  Market Size, By Application,  By Value, 2019–2030

Table 5        United States Hospital and Nursing Home Probiotics  Market Size, By Distribution Channel, By Value, 2019–2030

Table 6        Danone Company Overview

Table 7        Danone Financial Overview

Table 8        Nestlé Company Overview

Table 9        Nestlé Financial Overview

Table 10      Yakult Honsha Company Overview

Table 11      Yakult Honsha Financial Overview

Table 12      Probi AB Company Overview

Table 13      Probi AB Financial Overview

Table 14      Chr. Hansen Holding A/S Company Overview

Table 15      Chr. Hansen Holding A/S Financial Overview

Table 16      DuPont de Nemours Inc. Company Overview

Table 17      DuPont de Nemours Inc. Financial Overview

Table 18      BioGaia AB Company Overview

Table 19      BioGaia AB Financial Overview

Table 20      Lallemand Inc. Company Overview

Table 21      Lallemand Inc. Financial Overview

Table 22      Sabinsa Corporation Company Overview

Table 23      Sabinsa Corporation Financial Overview

Table 24      Nebraska Cultures Inc. Company Overview

Table 25      Nebraska Cultures Inc. Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: United States Hospital and Nursing Home Probiotics Market size by value was estimated at USD 110.20 million in 2023.
Ans: United States Hospital and Nursing Home Probiotics Market by value is expected to grow at a CAGR of 9.10% during the forecast period between 2024 and 2030.
Ans: United States Hospital and Nursing Home Probiotics Market size is forecast to reach a value of USD 197.76 million by 2030.
Ans: Growth of United States Hospital and Nursing Home Probiotics Market is primarily driven by rising demand for preventive healthcare, increasing awareness of probiotics' benefits, technological advancements, and a shift towards healthier lifestyles.
Ans: Key players in United States Hospital and Nursing Home Probiotics Market include Danone, Nestlé, Yakult Honsha, Probi AB, Chr. Hansen Holding A/S, DuPont de Nemours Inc., BioGaia AB, Lallemand Inc., Sabinsa Corporation, and Nebraska Cultures Inc.
Ans: The dietary supplement segment accounts for the highest market share of United States Hospital and Nursing Home Probiotics Market by product type.